Alnylam Pharmaceuticals
ALNY
#565
Rank
โ‚น3.859 T
Marketcap
โ‚น29,099
Share price
-0.47%
Change (1 day)
37.58%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend history for this company